MedPath

Evaluation and Comparison the effects of amitriptyline, ibuprofen and placebo in patients with irreversible pulpitis

Phase 3
Conditions
irreversible pulpitis.
Registration Number
IRCT20181208041882N2
Lead Sponsor
Yazd University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Healthy candidates with no specific systemic diseases(specially heart,hepatic and renal diseases)
Do not use any analgesic drugs within 4 hours before referral
Diagnosis of irreversible pulpitis based on pulp vitality tests

Exclusion Criteria

Using analgesic drugs before refer
Medical allergy to NSAIDs and Amitriptyline
Teeth with a history of trauma and teeth that have recently been endodontically or orthodontically experienced in the last 6 months
Pregnancy and Lactation

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduction in patient pain score. Timepoint: Pain score on presentation,Pain score during injection,Pain score during procedure,Pain score at home(the first 6-8 hours ). Method of measurement: Visual Analogue Scale.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath